tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alex Thompson, 101 are a BUY (88.6%), 13 are a HOLD (11.4%).
Analyst Alex Thompson, currently employed at STIFEL, carries an average stock price target met ratio of 59.14% that have a potential upside of 59.38% achieved within 158 days. Previously, Alex Thompson worked at UBS.
Alex Thompson’s has documented 210 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SYRE, Spyre Therapeutics at 06-May-2026.
Analyst best performing recommendations are on DICE (DICE MOLECULES HOLDINGS LLC).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 11/6/2024. The price target of $3 was fulfilled within 12 days with a profit of $0.74 (32.74%) receiving and performance score of 27.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Aug-2023
$48
$0.45 (0.95%)
$48
2 years 11 months 23 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold Since 26-Jun-2023
$56
3 years 1 months 6 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Buy Since 22-May-2023
$48
3 years 1 months 11 days ago
(21-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy Since 14-Sep-2022
$48
$0.45 (0.95%)
$68
3 years 1 months 12 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold Since 24-May-2023
$48
$0.45 (0.95%)
$38
3 years 1 months 12 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Which stock is Alex Thompson is most bullish on?
Which stock is Alex Thompson is most reserved on?
What Year was the first public recommendation made by Alex Thompson?
